Fig. 2From: High prevalence of de novo metabolic dysfunction-associated fatty liver disease after liver transplantation and the role of controlled attenuation parameterMedian CAP scores according to steatosis grade at (A) the time of liver implantation and (B) liver biopsy within 1 year of CAP measurementBack to article page